Purpose of the development: Pharmaceuticals are designed to stimulate the blood supply to the brain.

Technical characteristic: Product Feature: - Potassium salt of N- (1, 4-dioxo-3-chloro-1,4-digidronaft- 2-yl) alanine% dark red crystalline substance soluble in water, T. fuels. > 280 deg. S.

Advantages over analogues: Invited to a biologically active compound, more efficient than the closest analogues to act, known antihypoxants - "Emoksipin" "Piracetam," "Cavinton." New biologically active compounds are suitable for creating a more effective and safe therapeutic agents with the specified action.

Description of the development:
()
New biologically active compound - the potassium salt of N- (1,4-dioxo-3-chloro-1,4-dihydronaphth-2-yl) alanine, and which detects Antihypoxanth protivoishemichnye properties and effects on stimulated blood supply to the brain. Antigipoksichnogo largest effect in experimental acute asphyxia the rats in a dose of the test compound, which is 1% of the LD50 does not yield emoksipinu (10 mg / kg). In a model of acute cerebral ischemia in a dose which is 5% of the LD50, unlike Piracetam (100mg / kg) twice prolongs the life of the experimental animal. Compound (4 mg / kg i.v.) inherent expressive the stimulatory effect on cerebral blood flow and the duration for which the value is twice the effect Cavinton (5 mg / kg i.v.).

Information about newness of the development:
there are Ukrainian patents -- 1 items

Possibility of transfer abroad:
Licence's sale

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua